METHODS: The scoping review protocol and review follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Review. To identify eligible studies, we will search MEDLINE, PsycINFO, CINAHL and Web of Science. The reference lists of the included articles will be checked for additional studies. In addition, country-specific ministry reports from Member States of the European Union, the UK, Norway, Iceland and Switzerland will be identified. The WHO and European Commission websites will also be searched for relevant reports. The scoping review will include literature published until 20 September 2023. No restrictions to study design and language will be applied. Screening and data extraction will be carried out independently by three reviewers. Disagreements will be resolved by discussion. A pretested data charting table will be used to extract key information. Findings will be presented in tabular and visualised summaries and a narrative summary.
BACKGROUND: This scoping review does not require ethical approval. Our dissemination strategy comprises peer-reviewed publications, conference presentations and recommendations to policy-makers.
方法:范围审查方案和审查遵循系统审查的首选报告项目和范围审查的Meta分析扩展。为了确定符合条件的研究,我们将搜索MEDLINE,PsycINFO,CINAHL和WebofScience。将检查所包含文章的参考列表以进行其他研究。此外,欧洲联盟成员国针对具体国家的部报告,英国,挪威,冰岛和瑞士将被确定。世卫组织和欧盟委员会网站也将被搜索相关报告。范围审查将包括2023年9月20日之前发表的文献。对学习设计和语言没有限制。筛选和数据提取将由三名评审员独立进行。分歧将通过讨论解决。预先测试的数据图表表将用于提取关键信息。研究结果将以表格和可视化摘要以及叙述性摘要形式呈现。
背景:此范围审查不需要道德批准。我们的传播策略包括同行评审的出版物,会议向决策者介绍和建议。